FIELD: medicine, pharmacy. SUBSTANCE: ointment has the following components, weight %: piroxicam 0.5-10; hydrophobic carrier(s) 15-30; hydrophilic carrier(s) 60-75; addition(s) 0.1-10 and emulsifiers consisting of poly-(ethylene glycol)-alkyl or alkenyl ether and sorbitol ester of fatty or oleic acid at the weight ratio (3:1)-(1:3) 2-5. EFFECT: improved stability, safety of ointment. 6 cl, 6 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ASCOMYCIN-CONTAINING COMPOSITIONS FOR TOPICAL APPLICATION | 1999 |
|
RU2234319C2 |
| LOCAL COMPOSITION CONTAINING AMBROXOL | 2005 |
|
RU2381794C2 |
| LIQUID MEDICINAL FORM OF PIROXICAM | 1991 |
|
RU2062616C1 |
| COMPOSITION FOR SKIN CARE, INTENDED FOR LOCAL APPLICATION | 2003 |
|
RU2350313C2 |
| STABILIZATION OF RESORCINOL COMPOUNDS IN COSMETIC COMPOSITIONS | 2020 |
|
RU2818915C2 |
| CREAM "PIROKSIFEN" POSSESSING ANTIINFLAMMATORY AND ANALGETIC ACTION | 2001 |
|
RU2199307C1 |
| PHARMACEUTICAL COMPOSITION FOR LOCAL APPLICATION CONTAINING COMBINATION OF FUSIDIC ACID AND CORTICOSTEROID | 2008 |
|
RU2470645C2 |
| SPONTANEOUSLY DISPERSIBLE CONCENTRATE, PHARMACEUTICAL PREPARATION, THERAPEUTIC SYSTEMIC PREPARATION AND COMPOUNDS | 1991 |
|
RU2113219C1 |
| PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PSORIASIS | 2020 |
|
RU2742879C1 |
| ARYLSULPHONAMIDE-SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE INHIBITORS | 2005 |
|
RU2406721C2 |
